IRFILBRAYPriority claimed from 17/01/2023; Application No. : 18823417 ;European Union (Class 5)
#5919045
Application Number:5919045
Status:
Unknown
Class:5
Applicant: GENZYME CORPORATION
Filing Date:Tue, 02 May 2023
Get a free email alert the moment this application's status changes.
Trademark Information
| Trademark | IRFILBRAYPriority claimed from 17/01/2023; Application No. : 18823417 ;European Union |
| Trademark Type | Wordmark |
| Class | 5 |
| Application Number | 5919045 |
| Nature/Scope of business | Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of rare diseases notably lysosomal storage disorders and autosomal dominant polycystic kidney disease; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections |
| Publication | In Journal No. 2141 |
| Status | Unknown |
| Applicant: | GENZYME CORPORATION |
| Applicant Address | 450 Water Street, CAMBRIDGE, MA 02141, United States of America A Massachusetts corporation, USA |
| Jurisdiction | DELHI |
| Agent | REMFRY & SAGAR |
| Agent Address | REMFRY HOUSE AT THE MILLENNIUM PLAZA SEC 27, GURGAON 122009, NEW DELHI NATIONAL CAPITAL REGION INDIA |
Frequently Asked Questions
Who is the owner of trademark IRFILBRAYPriority claimed from 17/01/2023; Application No. : 18823417 ;European Union? ▾
The trademark application number 5919045 is owned by GENZYME CORPORATION.
Which class does trademark IRFILBRAYPriority claimed from 17/01/2023; Application No. : 18823417 ;European Union belong to? ▾
Trademark application number 5919045 is filed under Class 5, which relates to the specified goods and services.
Who is the trademark agent for application 5919045? ▾
The trademark agent associated with application number 5919045 is REMFRY & SAGAR.
Was trademark IRFILBRAYPriority claimed from 17/01/2023; Application No. : 18823417 ;European Union published in the journal? ▾
Yes, trademark application number 5919045 was published in Journal No. 2141.
What is trademark IRFILBRAYPriority claimed from 17/01/2023; Application No. : 18823417 ;European Union? ▾
Trademark application number 5919045 relates to "Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of rare diseases notably lysosomal storage disorders and autosomal dominant polycystic kidney disease; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections".
File Trademark at Just ₹1,499 + Govt Fees
Get your trademark registered with expert guidance. Limited time offer!
File NowExpert Consultation
Quick Processing
100% Support
Free Report
Get Detailed Trademark Report
Comprehensive analysis of your trademark search delivered to your phone
What you'll get:
- Complete trademark analysis
- Conflict assessment
- Registration guidance
15,000+Trademarks Filed
98%Success Rate
Govt Authorized
ISO Certified